危重症研究替代知情同意流程的实施效果:针对研究者、协调员、替代决策者与患者的多模式研究
该混合方法研究在美国多个学术医疗中心开展,通过定量调查(含开放式问题)、焦点小组和半结构化访谈,纳入主要研究者(PI)、研究协调员(RC)、被接触过危重症研究临床试验的替代决策者(SDM)以及尽可能纳入的重症患者。共230人完成调查(105名RC、90名PI、27名SDM、8名患者),61人参与焦点小组/访谈。各群体均认为应由RC而非PI实施知情同意流程,因RC不被视为权威人物且感知利益冲突较少;SDM对等待最佳接触时机、给予物理空间和定义考虑期表示认可;与PI/RC相比,SDM和/或患者在调查中更感激研究团队更新患者病情,并更热情认为研究的感知优势是帮助遵守临床方案(P < .0001,P = .0016);SDM认为书面同意更重要且较少关注其长度(P = .001,P < .0001);所有参与者认为电话/电子同意不如面对面有效,但可促进纳入居住较远的SDM。
要点
- 各群体均认为应由研究协调员(RC)而非主要研究者(PI)实施替代知情同意,因RC不被视为权威人物且感知利益冲突较少。
- SDM认可研究团队等待最佳时机接触、给予物理空间和定义考虑期。
- 与PI/RC相比,SDM和/或患者在调查中更感激研究团队更新患者病情(P < .0001),并更热情认为研究感知优势是帮助遵守临床方案(P = .0016)。
- 与PI/RC相比,SDM认为书面同意更重要(P = .001)且较少关注其长度(P < .0001)。
- 所有参与者认为电话/电子同意不如面对面有效,但可促进纳入居住较远的SDM。
适用人群与场景
- 美国学术医疗中心的主要研究者(PI)、研究协调员(RC)、被接触过危重症研究临床试验的替代决策者(SDM),以及尽可能纳入的重症患者。
研究设计与关键结果
- 混合方法研究,在美国多个学术医疗中心开展,共230人完成调查(105名RC、90名PI、27名SDM、8名患者),61人参与焦点小组/访谈。
- 各群体均认为应由RC而非PI实施知情同意流程,因RC不被视为权威人物且感知利益冲突较少。
- SDM认可研究团队等待最佳时机接触、给予物理空间和定义考虑期。
- 与PI/RC相比,SDM和/或患者在调查中更感激研究团队更新患者病情(P < .0001),并更热情认为研究的感知优势是帮助遵守临床方案(P = .0016)。
- 与PI/RC相比,SDM认为书面同意更重要(P = .001)且较少关注其长度(P < .0001)。
- 所有参与者认为电话/电子同意不如面对面有效,但可促进纳入居住较远的SDM。
证据类型、等级与局限
- 证据类型:混合方法研究(定量调查含开放式问题、焦点小组、半结构化访谈)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,本研究识别出若干可增强危重症研究替代知情同意流程的策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although surrogates are often required to participate in the informed consent process for critical care research, how to best engage surrogates in this process remains unclear.
RESEARCH QUESTION: What are the best practices for conducting the surrogate informed consent processes for critical care research?
STUDY DESIGN AND METHODS: This mixed-methods study was performed across academic medical centers located in the United States. It included quantitative surveys with open-ended questions, focus groups, and semi-structured interviews with principal investigators (PIs), research coordinators (RCs), and surrogate decision makers (SDMs) who were approached about a critical care research clinical trial and, when possible, the patient who had been critically ill. Both quantitative and qualitative thematic methods were used in the analysis.
RESULTS: In total, 230 individuals (105 RC, 90 PI, 27 surrogates, and 8 patients) completed surveys, and 61 participated in focus groups/interviews. In both surveys and focus groups/interviews, participants across all groups believed that RCs (as opposed to PIs) should conduct the consent process, as RCs are not considered to be authority figures and have fewer perceived conflicts of interest. Surrogates appreciated it when research staff waited until there was an optimal time to initiate contact and were given physical space and a defined period to consider their decision. Compared with PI/RCs, SDMs and/or patients (in surveys) expressed appreciation for the research team's updates on the patient's condition and were more enthusiastic that a perceived advantage of research was that it could help with adherence to clinical protocols (P < .0001, P = .0016). Compared with PI/RCs, SDMs thought the written consent was more important and were less concerned with its length (P = .001, P < .0001). All participants felt that telephone/electronic consents were less effective than in-person consent, although these modalities could facilitate the inclusion of SDMs who lived far away.
INTERPRETATION: This study identified several strategies that could enhance the surrogate informed consent process for critical care research.
参考来源
- Glaros C, Tietbohl CK, Torres KA, et al. The Performance of the Surrogate Informed Consent Process for Critical Care Research: A Multi-Modal Study of Investigators, Coordinators, Surrogates, and Patients. Chest. 2025. PMID: 40484371. doi:10.1016/j.chest.2025.05.038
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。